Search

everythinglearnresearchcommunity

for

Search:↓

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Compounds from turmeric and bitter show strong potential as antiviral agents against the influenza A virus.

Ruxolitinib cream may help treat severe hair loss in children.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

JAK inhibitors show promise for treating hair loss in alopecia areata but need more clinical trials to confirm safety and effectiveness.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

Ritlecitinib is effective for long-term treatment of severe alopecia areata.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

Cubosomal gels enhance skin absorption of cetirizine better than niosomal gels.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Janus kinase inhibitors are promising for treating scarring alopecia, but more research is needed for safety and personalized treatments.

Glibenclamide slows breast cancer cell growth by stopping cell division.

Tofacitinib may help treat hair loss in children with alopecia areata.

Ritlecitinib works well and is safe for treating alopecia areata.

Upadacitinib may effectively treat alopecia areata without side effects.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.